南财智讯11月27日电，ST中珠公告，公司董事会于2025年11月27日收到公司董事武有、独立董事张霞 送达的书面辞职报告。武有因个人原因，申请辞去公司董事、董事会审计委员会委员、董事会薪酬与考 核委员会委员职务。辞职后，武有不再担任公司任何职务。张霞因个人原因，申请辞去公司独立董事、 董事会战略委员会委员、董事会审计委员会召集人、董事会提名委员会委员、董事会薪酬与考核委员会 委员职务。辞职后，张霞不再担任公司任何职务。 ...

Core Viewpoint - The medical services sector experienced a decline of 1.34% on November 27, with ST Zhongzhu leading the losses, while the Shanghai Composite Index rose by 0.29% and the Shenzhen Component Index fell by 0.25% [1] Group 1: Market Performance - The closing price of ST Zhongzhu was 2.58, down 4.44%, with a trading volume of 1.5064 million shares and a transaction value of 398 million yuan [2] - Hai Te Biological saw a closing price of 31.61, up 5.58%, with a trading volume of 123,500 shares and a transaction value of 383 million yuan [1] - The medical services sector had a net outflow of 1.094 billion yuan from major funds, while retail investors saw a net inflow of 691 million yuan [2][3] Group 2: Individual Stock Performance - Major inflows were observed in Hai Te Biological with a net inflow of 16.0794 million yuan from major funds, while retail investors had a net outflow of 40.452 million yuan [3] - International Medical had a net inflow of 8.2364 million yuan from major funds, with a net outflow of 3.7632 million yuan from retail investors [3] - The stock of Bo Teng Co. had a net inflow of 10.6216 million yuan from major funds, while retail investors experienced a net outflow of 5.1912 million yuan [3]

登录新浪财经APP 搜索【信披】查看更多考评等级 上市公司名称：中珠医疗控股股份有限公司 股票上市地点：上海证券交易所 股票简称：ST中珠 股票代码：600568 信息披露义务人：深圳市深商控股集团股份有限公司 住所：深圳市南山区粤海街道麻岭社区科技中三路1号海王银河科技大厦20层 股份变动性质：股份减少（间接方式转让） 一、信息披露义务人根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证 券法》（以下简称"《证券法》"）、《上市公司收购管理办法》（以下简称"《收购管理办法》"）、 《公开发行证券的公司信息披露内容与格式标准第15号---权益变动报告书》（以下简称"《准则第15 号》"）及相关法律、法规和规范性文件编写本报告书。 二、本信息披露义务人签署本报告已获得必要的授权和批准，其履行亦不违反信息披露义务人章程或内 部规则中的任何条款，或与之相冲突。 三、依据《证券法》《收购管理办法》《准则第15号》的规定，本报告书已全面披露信息披露义务人在 中珠医疗控股股份有限公司中拥有权益的股份变动情况。 四、截至本报告书签署日，除本报告书披露的信息外，信息披露义务人没有通过任何其他方式增加或 ...

Group 1 - ST Zhongzhu announced the receipt of a share transfer agreement from Shenzhen Shenshang Holdings Group, where Shenshang plans to transfer 100% equity of its major shareholder, Shenzhen Landi Technology, to Suzhou Bubugao Investment Development for 30 million yuan [1] - After the transfer, Bubugao Investment will hold 380,172,862 shares of ST Zhongzhu, representing 19.08% of the total share capital [1] - Bubugao Investment stated that there are no plans to increase or decrease its stake in the company within the next 12 months, nor are there any major asset restructuring plans [1] Group 2 - On November 14, ST Zhongzhu announced that Qiongcheng Meihua Tenglong Qifei Investment Partnership intends to acquire 10.38% of the company's shares for 403 million yuan [2] - Qiongcheng Meihua Tenglong Qifei Investment Partnership, which is 80% owned by Wu Shichun, expressed confidence in the company's future development prospects and investment value [2] - The partnership aims to actively exercise shareholder rights to improve the company's operations, asset quality, and sustainable profitability [2]

Group 1 - ST Zhongzhu (sh600568) hit the daily limit down on November 27, 2025, with a closing price of 2.57 yuan, a decline of 4.07%, and a total market capitalization of 5.162 billion yuan [1] - The stock experienced a total trading volume of 113 million yuan by the time of reporting [1] Group 2 - The reasons for ST Zhongzhu's limit down include capital outflow, sector pressure, and declining concept heat: 1. Capital outflow pressure: On November 25, 2025, the stock's sell amount exceeded the buy amount, indicating some capital was leaving the market, which could negatively impact the stock price [2] 2. Poor sector performance: The overall underperformance of the healthcare services sector can exert pressure on ST Zhongzhu's stock price, as it is related to this sector [2] 3. Declining concept heat: Although the stock attracted market attention with the new "yesterday's consecutive board" concept on November 14, 2025, the excitement may have waned over time, leading to reduced buying interest and upward momentum [2] 4. Technical and capital influences: Recent capital flow trends show an outflow, and technical indicators such as MACD crossovers and BOLL channel breaches may exacerbate bearish market sentiment, contributing to the limit down [2]

Core Viewpoint - The report outlines the shareholding changes of Zhongzhu Medical Holdings Co., Ltd. due to the transfer of 100% equity of Landi Technology, which indirectly holds 19.08% of Zhongzhu Medical's shares, to Suzhou Bubugao. This transfer is driven by the need for funds by the disclosing party, Shenzhen Shenshang Holdings Group Co., Ltd. [1][6][10] Group 1 - The disclosing party has reduced its shareholding in Zhongzhu Medical through an indirect transfer of shares [1][2] - The disclosing party does not plan to increase or decrease its shareholding in the next 12 months [7] - The disclosing party has confirmed that there are no other means of increasing or decreasing its shareholding apart from what is disclosed in the report [2][5] Group 2 - The purpose of the equity change is to meet the disclosing party's funding needs [6] - The disclosing party held 380,172,862 shares of Zhongzhu Medical, representing 19.08% of the total share capital before the transfer [8][34] - After the transfer, the disclosing party will no longer hold any shares or voting rights in Zhongzhu Medical [9][10] Group 3 - The transfer agreement was signed on November 23, 2025, and involves the transfer of all rights and obligations associated with the 100% equity of Landi Technology [10][11] - The target company, Landi Technology, has been under judicial freeze since September 12, 2024, and the disclosing party is coordinating to lift this freeze [11][34] - The total assets of the target company as of June 30, 2025, were approximately 660 million RMB, with total liabilities of about 670 million RMB, resulting in a net asset of approximately -1 million RMB [12]

11月26日，ST中珠（600568）披露详式权益变动报告书，步步高投资实控人张源披露，在未来12个月内无增加或减少上市公司股份的具体计划，不谋求 上市公司控制权。据披露，张源已控制大千生态、利源股份两家A股上市公司，并持有港股上市公司巨星传奇6.07%的股份。 约两周前，吴世春控制的梅花投资刚以4.03亿元入股ST中珠，成为公司第二大股东。短期内，两大明星资本的接连入局，市场普遍期待这家长期无实控人 的公司将迎来转机。 11月26日，ST中珠再次收获涨停。 拟3000万元受让第一大股东股权 回溯来看，11月24日晚，ST中珠发布公告称，深商集团于前一日与苏州步步高投资发展有限公司（简称"步步高投资"）签署了《股权转让协议》，深商 集团拟以3000万元的价格将其持有的深圳市朗地科技发展有限公司（简称"朗地科技"）100%股权转让给步步高投资。 本次股权转让完成后，朗地科技控股股东将由深商集团变更为步步高投资。 作为知名的一级市场天使投资人，吴世春今年频频出手。除了入股ST中珠，他还通过司法拍卖和二级市场增持的方式成为ST路通第一大股东。 据查询，朗地科技目前持有ST中珠3.8亿股股份，占公司总股本的19.08 ...

中珠医疗控股股份有限公司 简式权益变动报告书 上市公司名称：中珠医疗控股股份有限公司 股票上市地点：上海证券交易所 股票简称：ST 中珠 股票代码：600568 信息披露义务人：深圳市深商控股集团股份有限公司 住所：深圳市南山区粤海街道麻岭社区科技中三路 1 号海王银河科技 大厦 20 层 股份变动性质：股份减少（间接方式转让） 签署日期：二零二五年十一月 信息披露义务人声明 一、信息披露义务人根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公司收购管理办法》 （以下简称"《收购管理办法》"）、《公开发行证券的公司信息披露内容与格式标 准第 15 号---权益变动报告书》（以下简称"《准则第 15 号》"）及相关法律、法 规和规范性文件编写本报告书。 二、本信息披露义务人签署本报告已获得必要的授权和批准，其履行亦不 违反信息披露义务人章程或内部规则中的任何条款，或与之相冲突。 七、本次权益变动尚需向工商登记管理部门办理本次变更登记手续及备案 手续。本次权益变动是否能通过相关部门审批及通过审批的时间存在一定的不 确定性，敬请广大投资者注意投资风 ...

南财智讯11月26日电，ST中珠公告，深圳市深商控股集团股份有限公司通过出让其持有的深圳市朗地 科技发展有限公司100%股权的方式，间接减持公司380,172,862股股份。本次权益变动前，深商控股通 过朗地科技间接持有公司19.08%股份；本次权益变动后，深商控股不再直接或间接持有公司任何股 份。截至本报告书签署日，朗地科技持有的公司股份存在质押和部分冻结情形，且本次权益变动尚需办 理工商变更登记手续，最终完成时间存在不确定性。 ...

ST中珠公告，信息披露义务人深圳市深商控股集团股份有限公司通过出让其持有的朗地科技100%股 权，间接减持公司19.08%股份。本次权益变动前，深商控股持有上市公司3.8亿股股份，占总股本的 19.08%。变动后，不再持有上市公司股份或表决权。 ...